News Focus
News Focus
icon url

BTH

11/05/10 2:30 PM

#108226 RE: poorgradstudent #108222

yes i know, the P3 JAK is in myelofibrosis, etc., but it still leaves no room for error with a market cap of $2 billion. Just my opinion.

icon url

mcbio

11/05/10 5:49 PM

#108255 RE: poorgradstudent #108222

Re: INCY/JAK inhibitor

the phase 3 isn't in RA.

INCY is developing a JAK2 inhibitor for RA though, aren't they? I thought it was at least in Phase 2.